These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 26339400)
1. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma. Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400 [TBL] [Abstract][Full Text] [Related]
2. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic intraepithelial neoplasia in the background of invasive ductal carcinoma of the pancreas as a prognostic factor. Oda Y; Aishima S; Morimatsu K; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Miyazaki T; Tanaka M; Oda Y Histopathology; 2014 Sep; 65(3):389-97. PubMed ID: 24931343 [TBL] [Abstract][Full Text] [Related]
4. Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer. Wang W; Gao J; Man XH; Li ZS; Gong YF Oncol Rep; 2009 Jun; 21(6):1439-47. PubMed ID: 19424621 [TBL] [Abstract][Full Text] [Related]
5. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models. Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057 [TBL] [Abstract][Full Text] [Related]
6. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma. Iakovlev V; Siegel ER; Tsao MS; Haun RS Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1135-42. PubMed ID: 22573795 [TBL] [Abstract][Full Text] [Related]
7. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Adsay NV; Basturk O; Cheng JD; Andea AA Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice. Osvaldt AB; Wendt LR; Bersch VP; Backes AN; de Cássia A Schumacher R; Edelweiss MI; Rohde L Surgery; 2006 Nov; 140(5):803-9. PubMed ID: 17084724 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934 [TBL] [Abstract][Full Text] [Related]
11. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas. Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281 [TBL] [Abstract][Full Text] [Related]
12. Survivin expression in pancreatic intraepithelial neoplasia (PanIN): steady increase along the developmental stages of pancreatic ductal adenocarcinoma. Bhanot U; Heydrich R; Möller P; Hasel C Am J Surg Pathol; 2006 Jun; 30(6):754-9. PubMed ID: 16723855 [TBL] [Abstract][Full Text] [Related]
13. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia. Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913 [TBL] [Abstract][Full Text] [Related]
14. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas. Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
16. Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC). Zińczuk J; Zaręba K; Romaniuk W; Kamińska D; Nizioł M; Baszun M; Kędra B; Guzińska-Ustymowicz K; Pryczynicz A Int J Med Sci; 2019; 16(4):583-592. PubMed ID: 31171910 [No Abstract] [Full Text] [Related]
17. Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients. Hwang IK; Kim H; Lee YS; Kim J; Cho JY; Yoon YS; Han HS; Hwang JH Cancer Sci; 2015 Oct; 106(10):1408-13. PubMed ID: 26183380 [TBL] [Abstract][Full Text] [Related]
18. Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression. Hutchings D; Waters KM; Weiss MJ; Wolfgang CL; Makary MA; He J; Cameron JL; Wood LD; Hruban RH Am J Surg Pathol; 2018 Nov; 42(11):1556-1561. PubMed ID: 30212393 [TBL] [Abstract][Full Text] [Related]
19. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma]. Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019 [TBL] [Abstract][Full Text] [Related]
20. HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. Yan H; Qiu W; Koehne de Gonzalez AK; Wei JS; Tu M; Xi CH; Yang YR; Peng YP; Tsai WY; Remotti HE; Miao Y; Su GH Cancer Lett; 2019 Feb; 442():333-340. PubMed ID: 30447255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]